$117.60
1.03% today
NYSE, Sep 16, 08:14 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$116.40
+8.16 7.54% 1M
-3.76 3.13% 6M
+6.33 5.75% YTD
+13.71 13.35% 1Y
-10.22 8.07% 3Y
+32.13 38.13% 5Y
+73.68 172.47% 10Y
NYSE, Closing price Fri, Sep 13 2024
-0.43 0.37%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Market capitalization $202.52b
Enterprise Value $210.30b
P/E (TTM) P/E ratio 36.74
EV/FCF (TTM) EV/FCF 37.20
EV/Sales (TTM) EV/Sales 5.16
P/S ratio (TTM) P/S ratio 4.97
P/B ratio (TTM) P/B ratio 5.15
Dividend yield 1.79%
Last dividend (FY23) $2.08
Revenue growth (TTM) Revenue growth 1.24%
Revenue (TTM) Revenue $40.73b
EBIT (operating result TTM) EBIT $6.61b
Free Cash Flow (TTM) Free Cash Flow $5.65b
Cash position $7.22b
EPS (TTM) EPS $3.17
P/E forward 34.44
P/S forward 4.85
EV/Sales forward 5.04
Short interest 0.74%
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Abbott Laboratories forecast:

19x Buy
70%
8x Hold
30%

Analyst Opinions

27 Analysts have issued a Abbott Laboratories forecast:

Buy
70%
Hold
30%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '23
+/-
%
40,109 40,109
8% 8%
100%
- Direct Costs 20,072 20,072
6% 6%
50%
20,037 20,037
10% 10%
50%
- Selling and Administrative Expenses 7,640 7,640
3% 3%
19%
- Research and Development Expense 2,719 2,719
5% 5%
7%
9,678 9,678
17% 17%
24%
- Depreciation and Amortization 3,243 3,243
1% 1%
8%
EBIT (Operating Income) EBIT 6,435 6,435
23% 23%
16%
Net Profit 5,701 5,701
17% 17%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
The Motley Fool
about 10 hours ago
Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run.
Positive
Seeking Alpha
3 days ago
Abbott's diversified growth, driven by innovative medical devices and established pharmaceuticals, positions it well for long-term success and market outperformance. Despite legal challenges and post-pandemic headwinds, Abbott's robust earnings growth and solid dividend profile make it an attractive investment. Abbott's strong innovation pipeline, including advancements in CGM systems, supports...
Positive
The Motley Fool
3 days ago
Dividend stocks that grow their payouts can be ideal income sources for investors to buy and hold. The stocks listed here have profitable and predictable businesses, making them safe options to invest in.
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today